S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
Log in

The9 Stock Forecast, Price & News

-8.54 (-20.71 %)
(As of 02/26/2021 12:00 AM ET)
Today's Range
Now: $32.69
50-Day Range
MA: $27.93
52-Week Range
Now: $32.69
Volume3.59 million shs
Average Volume6.78 million shs
Market Capitalization$99.38 million
P/E RatioN/A
Dividend YieldN/A
The9 Limited, together with its subsidiaries, operates and develops online games in the People's Republic of China. The company offers online games, including multiplayer online games, mobile games, Web games, and TV games. It also develops mobile games, including CrossFire New Mobile Game and Audition; and provides technical consulting services. The company was formerly known as GameNow.net Limited and changed its name to The9 Limited in February 2004. The9 Limited was founded in 1999 and is headquartered in Shanghai, the People's Republic of China.


Why The9 Limited Stock Got Crushed Today
February 26, 2021 |  finance.yahoo.com
See More Headlines

Industry, Sector and Symbol

Industry Business services, not elsewhere classified
Current SymbolNASDAQ:NCTY
Year FoundedN/A



Sales & Book Value

Annual Sales$50,000.00
Book Value($58.14) per share



Market Cap$99.38 million
Next Earnings Date4/29/2021 (Estimated)


Overall MarketRank

0.52 out of 5 stars

Computer And Technology Sector

1076th out of 1,523 stocks

Business Services, Not Elsewhere Classified Industry

135th out of 192 stocks

Analyst Opinion: 0.0Community Rank: 2.6Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
-8.54 (-20.71 %)
(As of 02/26/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive NCTY News and Ratings via Email

Sign-up to receive the latest news and ratings for NCTY and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

The9 (NASDAQ:NCTY) Frequently Asked Questions

What stocks does MarketBeat like better than The9?

Wall Street analysts have given The9 a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but The9 wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting The9?

The9 saw a increase in short interest in the month of January. As of January 15th, there was short interest totaling 598,200 shares, an increase of 441.4% from the December 31st total of 110,500 shares. Based on an average trading volume of 3,660,000 shares, the days-to-cover ratio is presently 0.2 days. Currently, 10.1% of the shares of the stock are short sold.
View The9's Short Interest

When is The9's next earnings date?

The9 is scheduled to release its next quarterly earnings announcement on Thursday, April 29th 2021.
View our earnings forecast for The9

How has The9's stock been impacted by Coronavirus (COVID-19)?

The9's stock was trading at $6.3870 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, NCTY shares have increased by 411.8% and is now trading at $32.69.
View which stocks have been most impacted by COVID-19

When did The9's stock split? How did The9's stock split work?

The9's stock reverse split on the morning of Monday, October 19th 2020. The 1-10 reverse split was announced on Tuesday, October 13th 2020. The number of shares owned by shareholders was adjusted after the market closes on Friday, October 16th 2020. An investor that had 100 shares of The9 stock prior to the reverse split would have 10 shares after the split.

Who are The9's key executives?

The9's management team includes the following people:
  • Mr. Jun Zhu, Co-Founder, Chairman & CEO (Age 54)
  • Mr. Chris Shen, Pres (Age 53)
  • Mr. Kwok Ho Lai, CFO & Director (Age 44)
  • Wendy Weng, Mang. of Investor Relations

Who are some of The9's key competitors?

What other stocks do shareholders of The9 own?

Based on aggregate information from My MarketBeat watchlists, some companies that other The9 investors own include Amarin (AMRN), Gevo (GEVO), Biocept (BIOC), Nabriva Therapeutics (NBRV), Occidental Petroleum (OXY), Acasti Pharma (ACST), Anavex Life Sciences (AVXL), BIOLASE (BIOL), EyePoint Pharmaceuticals (EYPT) and Jaguar Health (JAGX).

What is The9's stock symbol?

The9 trades on the NASDAQ under the ticker symbol "NCTY."

Who are The9's major shareholders?

The9's stock is owned by a number of retail and institutional investors. Top institutional shareholders include Paloma Partners Management Co (1.23%).

Which institutional investors are buying The9 stock?

NCTY stock was bought by a variety of institutional investors in the last quarter, including Paloma Partners Management Co.

How do I buy shares of The9?

Shares of NCTY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is The9's stock price today?

One share of NCTY stock can currently be purchased for approximately $32.69.

How much money does The9 make?

The9 has a market capitalization of $99.38 million and generates $50,000.00 in revenue each year.

How many employees does The9 have?

The9 employs 61 workers across the globe.

What is The9's official website?

The official website for The9 is www.the9.com.

Where are The9's headquarters?

The9 is headquartered at BUILDING NO.3 690 BIBO ROAD ZHANG JIANG HI-TECH PARK, SHANGHAI F4, 201203.

How can I contact The9?

The9's mailing address is BUILDING NO.3 690 BIBO ROAD ZHANG JIANG HI-TECH PARK, SHANGHAI F4, 201203. The technology company can be reached via phone at 86-21-5172-9999 or via email at [email protected]

This page was last updated on 2/28/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.